-transparent.png){kind=logo}
Etomidate, an imidazole-containing anesthetic agent, is shown to be a reversible inhibitor of rabbit liver microsomal enzymes in vitro. Inhibition of aniline hydroxylation by etomidate follows competitive kinetics, while inhibition of microsomal N-demethylase and O-demethylase activities is of the mixed type. The concentrations of etomidate required to cause 50% inhibition of these enzyme activities are in the 7-10 microM range. NADPH-cytochrome c reductase is not inhibited by concentrations of etomidate below 100 microM. Spectrophotometric studies show that the addition of etomidate to liver microsomes results in a type II binding spectrum. We suggest that etomidate binds with high affinity to cytochrome(s) P-450, resulting in the inhibition of liver drug metabolism.
Y Horai, and
P F White, and
A J Trevor
January 1981,
Drug metabolism and disposition: the biological fate of chemicals,
Y Horai, and
P F White, and
A J Trevor
January 1983,
Molecular pharmacology,
Y Horai, and
P F White, and
A J Trevor
April 1970,
Biochemical pharmacology,
Y Horai, and
P F White, and
A J Trevor
January 1967,
Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
Y Horai, and
P F White, and
A J Trevor
September 1962,
The Journal of pharmacology and experimental therapeutics,
Y Horai, and
P F White, and
A J Trevor
May 1976,
Archives internationales de pharmacodynamie et de therapie,
Y Horai, and
P F White, and
A J Trevor
May 1977,
Biochemical pharmacology,
Y Horai, and
P F White, and
A J Trevor
July 1980,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Y Horai, and
P F White, and
A J Trevor
January 1972,
Annales chirurgiae et gynaecologiae Fenniae,
Y Horai, and
P F White, and
A J Trevor
November 1980,
Biochemical pharmacology,
